Effect of an insulin sensitizer agent, lipid lowering agent and an antioxidant on non - alcoholic fatty liver in rats / Abeer Ali Ebrahim Elnaggar ; Supervised Hekma Abdellatif , Afaf A. Ain Shoka , Fatma Abdellatif Ebeid
Material type: TextLanguage: English Publication details: Cairo : Abeer Ali Ebrahim Elnaggar , 2015Description: 179 P. : charts ; 25cmOther title:- تأثير عامل مخفض للدهون و عامل محفز للأنسولين بدون أو مصاحب لعامل مضاد للأكسدة على الكبد الدهنى الغير كحولى فى الجرذان [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.09.M.Sc.2015.Ab.E (Browse shelf(Opens below)) | Not for loan | 01010110067642000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.09.M.Sc.2015.Ab.E (Browse shelf(Opens below)) | 67642.CD | Not for loan | 01020110067642000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
The prevalence of non - alcoholic fatty liver disease (NAFLD) has markedly increased, especially with patient exhibit one or more features of the metabolic syndrome. This study investigates the effect of rosuvastatin (RSV), pioglitazone (PGZ) or/and Ý-carotene (ÝC) in NAFLD - induced rats. Rats were classified into 13 groups; normal (I), NAFLD - induced with high - fat diet (HFD; II), NAFLD switched to regular diet (RD; III), NAFLD - HFD or NAFLD - RD treated with RSV (IV, V), PGZ (VI,VII), ÝC (VIII, IX) RSV + ÝC (X, XI) and PGZ + ÝC (XII,XIII). respectively for 4 wk (weeks 13 - 16) and then killed to obtain serum samples and liver tissues. Liver histology, lipid profile, liver oxidative stress markers, and adipocytokines were measured. Liver sections of NAFLD - HFD rats revealed steatosis, loss of hepatic architectecture, inflammation and hepatocyte vacuolation with high percentage of cell fibrosis. Serum levels of ALT, AST, ALP, GGT and lipid profile (triglycerides, cholesterol, LDL and VLDL) was significantly increased (P < 0.05) compared with normal group. Also, hepatic MDA level and serum NASH biomarkers; leptin, TNF - Ü and TGF-Ý1 were furthermore increased
Issued also as CD
There are no comments on this title.